Lonestar Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Lonestar Capital Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-146,879	Closed	-$17K	–	18
2016 Q1	$17K	Hold	146,879	–	–	0.01%	11
2015 Q4	$17K	Buy	+146,879	New	+$20.7K	0.01%	13
2015 Q2	–	Sell	-1,821,700	Closed	-$1.24M	–	24
2015 Q1	$1.24M	Buy	1,821,700 +521,700	+40%	+$365K	0.63%	15
2014 Q4	$1.03M	Buy	+1,300,000	New	+$888K	1.14%	8

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

CPM

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

NGA

New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Lonestar Capital Management's GCVRZ Position: Q2 2016 in Review

Lonestar Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2016, closing a stake of 146,879 shares — an estimated $17K sold.

Lonestar Capital Management first reported a position in GCVRZ in Q4 2014 and held it in 4 quarters. The position peaked at $1.24M in Q1 2015. 109 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2016.

Lonestar Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q2 2016 after selling out during the quarter.
Lonestar Capital Management sold 146,879 Sanofi Contingent Value Rights shares in Q2 2016, an estimated $17K.
Lonestar Capital Management first reported a position in Sanofi Contingent Value Rights in Q4 2014 and held it in 4 quarters.
Lonestar Capital Management's Sanofi Contingent Value Rights position peaked at $1.24M in Q1 2015.
109 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2016.

Based on Lonestar Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.